Low-dose inhaled and nasal corticosteroid use and the risk of cataracts.

Authors:P Ernst, M Baltzan, J Deschênes, S Suissa
Language:Eng.
Date:2006-06-14
Journal:The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology (0903-1936)
Release:Eur Respir J. 2006 Jun;27(6):1168-74


Abstract:



Orally inhaled corticosteroid use has been convincingly linked to an increase in the risk of cataracts, although the risk at lower doses in common use remains uncertain. The potential risk of cataracts with the use of nasal corticosteroids is unknown. A matched nested case-control analysis was performed in a population-based cohort of elderly people who had been dispensed medications for airway disease, as identified through a universal drug benefit plan. Inhaled corticosteroid use was associated with a dose-related increase in both the risk of all cataracts and severe cataracts requiring extraction, and the increase in risk of severe cataracts was apparent even at daily doses of
Copyright:The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology

Division of Clinical Epidemiology, Royal Victoria Hospital, 687 Pine Avenue West, Ross 4.29, Montreal, Québec H3A 1A1, Canada. Pierre.ernst clinepi.mcgill.ca
Full text:
DOI - The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology (DOI)
HighWire Press - HTML (Free)
Terms:Administration, Inhalation, Adrenal Cortex Hormones, Aged, Aged, 80 and over, Case-Control Studies, Cataract, Cohort Studies, Dose-Response Relationship, Drug, Female, Humans, Male, Pulmonary Disease, Chronic Obstructive, Quebec, Risk